| Online-Ressource |
Verfasst von: | Hundemer, Michael [VerfasserIn]  |
| Klein, Ulrike [VerfasserIn]  |
| Hose, Dirk [VerfasserIn]  |
| Raab, Marc-Steffen [VerfasserIn]  |
| Cremer, Friedrich Walter [VerfasserIn]  |
| Jauch, Anna [VerfasserIn]  |
| Benner, Axel [VerfasserIn]  |
| Heiß, Christiane [VerfasserIn]  |
| Moos, Marion [VerfasserIn]  |
| Ho, Anthony Dick [VerfasserIn]  |
| Goldschmidt, Hartmut [VerfasserIn]  |
Titel: | Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14) |
Verf.angabe: | M. Hundemer, U. Klein, D. Hose, M.-S. Raab, F. W. Cremer, A. Jauch, A. Benner, C. Heiss, M. Moos, A.D. Ho and H. Goldschmidt |
E-Jahr: | 2007 |
Jahr: | 24 September 2007 |
Umfang: | 5 S. |
Illustrationen: | Diagramme |
Teil: | volume:40 |
| year:2007 |
| number:11 |
| pages:1033-1037 |
| extent:5 |
Fussnoten: | Gesehen am 20.10.2021 |
Titel Quelle: | Enthalten in: Bone marrow transplantation |
Ort Quelle: | London : Springer Nature, 1997 |
Jahr Quelle: | 2007 |
Band/Heft Quelle: | 40(2007), 11, Seite 1033-1037 |
ISSN Quelle: | 1476-5365 |
Abstract: | Lack of CD56 expression was reported to be associated with a poor prognosis in multiple myeloma (MM) patients treated with conventional chemotherapy. Aim of our retrospective study was to analyse whether CD56 expression on MM cells reveals as a prognostic factor in patients treated with high-dose chemotherapy. MM cells of 99 patients prior to treatment with high-dose chemotherapy were analysed for CD56 expression by flow cytometry. Multivariable analysis of event-free survival in these patients showed no statistically significant difference between the CD56(-) (n=28) and the CD56(+) (n=71) group. The lack of CD56 expression on MM cells of these patients correlated significantly with the presence of translocation (11;14) (t(11;14)) (estimated correlation coefficient=0.655 95%, confidence interval (0.481; 0.779)). In summary, our results indicate that lack of CD56 expression on MM cells is not a prognostic marker in patients treated with high-dose chemotherapy, but is associated with t(11;14). |
DOI: | doi:10.1038/sj.bmt.1705857 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.1038/sj.bmt.1705857 |
| DOI: https://doi.org/10.1038/sj.bmt.1705857 |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | Adult |
| Aged |
| Biomarkers |
| CD56 Antigen |
| Chromosomes, Human, Pair 11 |
| Chromosomes, Human, Pair 17 |
| Disease-Free Survival |
| Dose-Response Relationship, Drug |
| Female |
| Hematopoietic Stem Cell Transplantation |
| Humans |
| Male |
| Melphalan |
| Middle Aged |
| Multiple Myeloma |
| Myeloablative Agonists |
| Retrospective Studies |
| Translocation, Genetic |
| Transplantation, Autologous |
K10plus-PPN: | 1774614952 |
Verknüpfungen: | → Zeitschrift |
Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14) / Hundemer, Michael [VerfasserIn]; 24 September 2007 (Online-Ressource)